CAMP
CAMP4 Therapeutics·NASDAQ
--
--(--)
--
--(--)
CAMP fundamentals
CAMP4 Therapeutics (CAMP) released its earnings on Aug 14, 2025: revenue was 1.50M (YoY --), beat estimates; EPS was -0.62 (YoY +98.82%), beat estimates.
Revenue / YoY
1.50M
--
EPS / YoY
-0.62
+98.82%
Report date
Aug 14, 2025
EPS
Actual | -0.62 | -0.62 |
Forecast | -0.6938 | -0.6725 |
Surprise | +10.64% | +7.81% |
Revenue
Actual | 858.00K | 1.50M |
Forecast | 214.50K | 571.78K |
Surprise | +300.00% | +161.81% |
Earnings Call
You can ask Aime
What were the key takeaways from CAMP4 Therapeutics’s earnings call?What guidance did CAMP4 Therapeutics's management provide for the next earnings period?Did CAMP4 Therapeutics beat or miss consensus estimates last quarter?What factors drove the changes in CAMP4 Therapeutics's revenue and profit?What is CAMP4 Therapeutics's gross profit margin?What does CAMP4 Therapeutics do and what are its main business segments?What is the market's earnings forecast for CAMP4 Therapeutics next quarter?What is the revenue and EPS growth rate for CAMP4 Therapeutics year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
